192 related articles for article (PubMed ID: 35856268)
1. Inter-pathologist agreement on diagnosis, classification and grading of canine glioma.
Krane GA; Shockley KR; Malarkey DE; Miller AD; Miller CR; Tokarz DA; Jensen HL; Janardhan KS; Breen M; Mariani CL
Vet Comp Oncol; 2022 Dec; 20(4):881-889. PubMed ID: 35856268
[TBL] [Abstract][Full Text] [Related]
2. Canine intracranial gliomas: relationship between magnetic resonance imaging criteria and tumor type and grade.
Bentley RT; Ober CP; Anderson KL; Feeney DA; Naughton JF; Ohlfest JR; O'Sullivan MG; Miller MA; Constable PD; Pluhar GE
Vet J; 2013 Nov; 198(2):463-71. PubMed ID: 24051197
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of stereotactic brain biopsy for intracranial neoplasia in dogs: Comparison of biopsy, surgical resection, and necropsy specimens.
Kani Y; Cecere TE; Lahmers K; LeRoith T; Zimmerman KL; Isom S; Hsu FC; Debinksi W; Robertson JL; Rossmeisl JH
J Vet Intern Med; 2019 May; 33(3):1384-1391. PubMed ID: 30990928
[TBL] [Abstract][Full Text] [Related]
4. Canine Gliomatosis Cerebri: Morphologic and Immunohistochemical Characterization Is Supportive of Glial Histogenesis.
Rissi DR; Donovan TA; Porter BF; Frank C; Miller AD
Vet Pathol; 2021 Mar; 58(2):293-304. PubMed ID: 33357125
[TBL] [Abstract][Full Text] [Related]
5. A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.
Koehler JW; Miller AD; Miller CR; Porter B; Aldape K; Beck J; Brat D; Cornax I; Corps K; Frank C; Giannini C; Horbinski C; Huse JT; O'Sullivan MG; Rissi DR; Mark Simpson R; Woolard K; Shih JH; Mazcko C; Gilbert MR; LeBlanc AK
J Neuropathol Exp Neurol; 2018 Nov; 77(11):1039-1054. PubMed ID: 30239918
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of neural stem cell lineage markers in canine brains, gliomas, and a glioma cell line.
Yoshida K; Chambers JK; Uchida K
Vet Pathol; 2023 Jan; 60(1):35-46. PubMed ID: 36384382
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas.
de la Fuente C; Pumarola M; Blasco E; Fernández F; Viu J; Añor S
Vet J; 2014 Jun; 200(3):387-92. PubMed ID: 24745770
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, diagnosis, and survival analysis of dogs with glioma.
José-López R; Gutierrez-Quintana R; de la Fuente C; Manzanilla EG; Suñol A; Pi Castro D; Añor S; Sánchez-Masian D; Fernández-Flores F; Ricci E; Marioni-Henry K; Mascort J; Matiasek LA; Matiasek K; Brennan PM; Pumarola M
J Vet Intern Med; 2021 Jul; 35(4):1902-1917. PubMed ID: 34117807
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging features of intracranial astrocytomas and oligodendrogliomas in dogs.
Young BD; Levine JM; Porter BF; Chen-Allen AV; Rossmeisl JH; Platt SR; Kent M; Fosgate GT; Schatzberg SJ
Vet Radiol Ultrasound; 2011; 52(2):132-41. PubMed ID: 21388463
[TBL] [Abstract][Full Text] [Related]
10. Glioma with cribriform plate involvement in 6 dogs.
Reyes VAA; Howerth EW; Blas-Machado U; Platt SR; Pavarini SP; Castro LT; Church ME; Rissi DR
J Vet Diagn Invest; 2023 Nov; 35(6):800-805. PubMed ID: 37608783
[TBL] [Abstract][Full Text] [Related]
11. Intra- and inter-observer agreement in histological assessment of canine soft tissue sarcoma.
Yap FW; Rasotto R; Priestnall SL; Parsons KJ; Stewart J
Vet Comp Oncol; 2017 Dec; 15(4):1553-1557. PubMed ID: 28133880
[TBL] [Abstract][Full Text] [Related]
12. The T2-FLAIR mismatch sign as an imaging biomarker for oligodendrogliomas in dogs.
Garcia-Mora J; Parker RL; Cecere T; Robertson JL; Rossmeisl JH
J Vet Intern Med; 2023; 37(4):1447-1454. PubMed ID: 37246729
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the impact of glioma diagnostic reclassification following the new 2016 WHO classification on a series of cases.
Valera-Melé M; Mateo Sierra O; Sola Vendrell E; Guzmán de Villoria L JA; Carvajal Díaz L; Gil de Sagredo Del Corral ÓL; García Leal R
Neurocirugia (Astur : Engl Ed); 2019; 30(1):19-27. PubMed ID: 30366644
[TBL] [Abstract][Full Text] [Related]
14. Molecular signalling pathways in canine gliomas.
Boudreau CE; York D; Higgins RJ; LeCouteur RA; Dickinson PJ
Vet Comp Oncol; 2017 Mar; 15(1):133-150. PubMed ID: 25808605
[TBL] [Abstract][Full Text] [Related]
15. Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
Vet Pathol; 2016 Nov; 53(6):1131-1137. PubMed ID: 27154542
[TBL] [Abstract][Full Text] [Related]
16. [Grading of astrocytomas and oligodendrogliomas].
Kolles H; Niedermayer I; Feiden W
Pathologe; 1998 Jul; 19(4):259-68. PubMed ID: 9746910
[TBL] [Abstract][Full Text] [Related]
17. Prognostic histopathologic features of canine glial tumors.
Merickel JL; Pluhar GE; Rendahl A; O'Sullivan MG
Vet Pathol; 2021 Sep; 58(5):945-951. PubMed ID: 34219560
[TBL] [Abstract][Full Text] [Related]
18. Cerebral high-grade oligodendroglioma with sarcomatous transdifferentiation ("oligosarcoma") in a boxer dog.
Fadda A; Vajtai I; Lang J; Henke D; Oevermann A
J Vet Intern Med; 2014; 28(6):1881-5. PubMed ID: 25410956
[No Abstract] [Full Text] [Related]
19. Molecular profile of tumors with oligodendroglial morphology: Clinical relevance.
Geevar T; Pai R; Chacko G; Malepathi K; Patel B; John J; Chacko AG; Balakrishnan R; John S
Neurol India; 2018; 66(6):1726-1731. PubMed ID: 30504574
[TBL] [Abstract][Full Text] [Related]
20. Presence of neural progenitors in spontaneous canine gliomas: A histopathological and immunohistochemical study of 20 cases.
Fernández F; Deviers A; Dally C; Mogicato G; Delverdier M; Cauzinille L; Gnirs K; Añor S; de la Fuente C; Fondevila D; Pumarola M
Vet J; 2016 Mar; 209():125-32. PubMed ID: 26831167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]